The Joint British Diabetes Societies (JBDS) for Inpatient Care group was created in 2008 to ‘deliver a set of diabetes inpatient guidelines and proposed standards of care within secondary care organisations’, with the overall aim of improving inpatient diabetes care through the development and use of high quality evidence based guidelines, and through better inpatient care pathways.

Yue Ruan, Robert E J Ryder, Parijat De, Benjamin C T Field, Parth Narendran, Ahmed Iqbal, Rajiv Gandhi, Sophie Harris, Dinesh Nagi, Umaira Aziz, Efthimia Karra, Sandip Ghosh, Wasim Hanif, Amy E Edwards, Mansoor Zafar, Umesh Dashora, Kinga A Várnai, Jim Davies, Sarah H Wild, Emma G Wilmot, David Webb, Kamlesh Khunti, Rustam Rea, ABCD Covid-19 audit group

Dinesh Nagi, Robert EJ Ryder, Yue Ruan, Benjamin CT Field, Parth Narendran, Rajiv Gandhi, Sophie Harris, Kinga A Várnai, Jim Davies, Sarah H Wild, Emma G Wilmot, Kamlesh Khunti, Rustam Rea on behalf of the ABCD Covid-19 audit group

Canagliflozin, Dapagliflozin and Empagliflozin

Edwards AE, Entwistle A; Jaafar N, Margari N; Gelding SV, Gunganah K
Department of Diabetes and Endocrinology, Newham University Hospital, London, UK

Canagliflozin, Empagliflozin and Dapagliflozin audits

DTN-UK recommendations for access to Flash Glucose Monitoring.

The Joint British Diabetes Societies (JBDS) for Inpatient Care group was created in 2008 to ‘deliver a set of diabetes inpatient guidelines and proposed standards of care within secondary care organisations’, with the overall aim of improving inpatient diabetes care through the development and use of high quality evidence based guidelines, and through better inpatient care pathways.